Chadi sits down with three experts from the Cancer and Aging Research Group and contributors to the ASCO guideline on geriatric oncology: William Dale, MD, PhD, FASCO, City of Hope Comprehensive Cancer Center; Supriya Mohile, MD, MS, University of Rochester; and Heidi Klepin, MD, MS, Wake Forest University. The group explores the cutting-edge developments in geriatric oncology, from geriatric assessment and predicting patient outcomes to the ASCO guideline on incorporating geriatric assessment and subsequent systemic therapy into practice. If you’re a healthcare professional or simply interested in the intersection of aging and cancer treatment, this conversation offers a concise yet comprehensive overview of this vital field.
N/A
Dr. Simrit Parmar, founder of Cellenkos, joins the show to discuss her journey from the lab to the biotech startup world, detailing the inspiration behind launching her company, the challenges of securing funding, and the resilience required to overcome rejections. She shares insights into Cellenkos’ lead product, its progress toward market approval, and the rigorous
Carol Rausch—a healthcare professional, cancer researcher, and former patient with lymphoma—shares how her journey from researcher to patient transformed her understanding of medical language. She discusses the impact of word choice on patients, why certain battle and war metaphors can be harmful, and how language used in clinical settings differs from what resonates with those
Drs. David Braun and Toni Choueiri join to discuss a groundbreaking Nature study on a personalized neoantigen vaccine for adjuvant renal cell carcinoma. They explore the inspiration behind the trial, how the vaccine was developed and administered, and its safety profile. The conversation also covers patient outcomes after 3-4 years, including immune responses and disease
